Ian Frank

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
502 Johnson Pavilion
3610 Hamilton Walk 6073
Philadelphia, PA 19104-6073
Office: 215-662-7419
Fax: 215-349-8011
AB (Russian)
Dartmouth College, 1977.
MD (Medicine)
Dartmouth Medical School, 1980.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

HIV and AIDS, Lesbian, Gay, Bisexual and Transgender Health (LGBT)

Selected Publications

Fishman J, Taylor L, Frank I: Awareness of HPV and Uptake of Vaccination in a High-Risk Population. Pediatrics 138(2), Aug 2016.

Bednar MM, Hauser BM, Zhou S, Jacobson JM, Eron JJ, Frank I, Swanstrom R: Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment Discontinuation. The Journal of infectious diseases 214(3): 403-7, Aug 2016.

Ravimohan S, Tamuhla N, Nfanyana K, Steenhoff AP, Letlhogile R, Frank I, MacGregor RR, Gross R, Weissman D, Bisson GP: Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome. Clin Infect Dis 62(6): 795-803, Mar 2016.

Dinges Warren, Girard Pierre-Marie, Podzamczer Daniel, Brockmeyer Norbert H, García Felipe, Harrer Thomas, Lelievre Jean-Daniel, Frank Ian, Colin De Verdière Nathalie, Yeni Guy-Patrick, Ortega Gonzalez Enrique, Rubio Rafael, Clotet Sala Bonaventura, DeJesus Edwin, Pérez-Elias Maria Jesus, Launay Odile, Pialoux Gilles, Slim Jihad, Weiss Laurence, Bouchaud Olivier, Felizarta Franco, Meurer Anja, Raffi François, Esser Stefan, Katlama Christine, Koletar Susan L, Mounzer Karam, Swindells Susan, Baxter John D, Schneider Stefan, Chas Julie, Molina Jean-Michel, Koutsoukos Marguerite, Collard Alix, Bourguignon Patricia, Roman François: The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial. Medicine 95(6): e2673, Feb 2016.

Beck JM, Schloss PD, Venkataraman A, Twigg IH, Jablonski KA, Bushman FD, Campbell TB, Charlson ES, Collman RG, Crothers K, Curtis JL, Drews KL, Flores SC, Fontenot AP, Foulkes MA, Frank I, Ghedin E, Huang L, Lynch SV, Morris A, Palmer BE, Schmidt TM, Sodergren E, Weinstock GM, Young VB, Lung HIV Microbiome Project: Multi-center Comparison of Lung and Oral Microbiomes of HIV-infected and HIV-uninfected Individuals. American journal of respiratory and critical care medicine 192(11): 1335-44, Dec 2015.

Fuchs JD, Frank I, Elizaga ML, Allen M, Frahm N, Kochar N, Li S, Edupuganti S, Kalams SA, Tomaras GD, Sheets R, Pensiero M, Tremblay MA, Higgins TJ, Latham T, Egan MA, Clarke DaK, Eldridge JH, HVTN 090 Study Group and the National Institutes of Allergy and Infectious Diseases HIV Vaccine Trials Network, Mulligan M, Rouphael N, Estep S, Rybczyk K, Dunbar D, Buchbinder S, Wagner T, Isbell R, Chinnell V, Bae J, Escamilla G, Tseng J, Fair R, Ramirez S, Broder G, Briesemeister L, Ferrara A: First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090). Open forum infectious diseases 2(3): ofv082, Sep 2015.

Koblin BA, Grant S, Frye V, Superak H, Sanchez B, Lucy D, Dunbar D, Graham P, Madenwald T, Escamilia G, Swann E, Morgan C, Novak RM, Frank I: HIV Sexual Risk and Syndemics among Women in Three Urban Areas in the United States: Analysis from HVTN 906. Journal of urban health : bulletin of the New York Academy of Medicine 92(3): 572-83, Jun 2015.

Overton ET, Stapleton J, Frank I, Hassler S, Goepfert PA, Barker D, Wagner E, von Krempelhuber A, Virgin G, Meyer TP, Müller J, Bädeker N, Grünert R, Young P, Rösch S, Maclennan J, Arndtz-Wiedemann N, Chaplin P: Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial. Open forum infectious diseases 2(2): ofv040, May 2015.

Eberhart MG, Yehia BR, Hillier A, Voytek CD, Fiore DJ, Blank M, Frank I, Metzger DS, Brady KA: Individual and community factors associated with geographic clusters of poor HIV care retention and poor viral suppression. Journal of acquired immune deficiency syndromes (1999) 69 Suppl 1: S37-43, May 2015.

Hay CM, Wilson GJ, Elizaga M, Li S, Kochar N, Allen M, Sobieszczyk M, Frank I, Frahm N, Tomaras GD, Egan M, Pensiero M, Eldridge J: An HIV DNA Vaccine Delivered by Electroporation and Boosted by rVSV HIV-1 Gag Is Safe and Immunogenic in Healthy HIV-uninfected Adults. AIDS research and human retroviruses 30 Suppl 1: A17, Oct 2014.

back to top
Last updated: 03/07/2017
The Trustees of the University of Pennsylvania